How to transition from Fin to DUT?
    Finasteride/Dutasteride 8/2/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) every other day 6 years
    💧 Minoxidil (topical) 6 years
    💊 Minoxidil (oral) daily 3 months
    💊 Dutasteride (oral) every other day 3 months
    the tone is 😀 positive with significant improvements results.

    Other terms

    The user switched from oral finasteride and topical minoxidil to oral minoxidil and dutasteride, seeing improvements in hair growth. Most users suggest continuing with dutasteride and possibly phasing out finasteride, as dutasteride is a stronger DHT blocker.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Systemic treatment options for androgenic alopecia

      March 2026 in “Lithuanian University of Health Sciences”
      In this study, a systematic review found that for androgenetic alopecia, systemic treatments like finasteride, dutasteride, and oral minoxidil are effective at slowing progression and promoting hair regrowth, with additional antiandrogen therapy options for women.

      research Updates in Treatment for Androgenetic Alopecia

      January 2025 in “Annals of Dermatology”
      This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.

      research The inflammatory component of androgenetic alopecia

      3 citations , November 2021 in “Journal of The American Academy of Dermatology”
      This article discusses hormonal mechanisms underlying androgenetic alopecia but does not report any new findings; it reviews the roles of dihydrotestosterone and available FDA-approved treatments.

      research Nanotechnology-based topical treatments for androgenic alopecia

      June 2025 in “Nanomedicine”
      This abstract introduces androgenic alopecia as the most common form of non-cicatricial alopecia, which predominantly affects men but also has a significant occurrence in women; however, specific research results or conclusions about treatments or mechanisms are not reported in the summary.